New allergy shot for teens enters human testing
NCT ID NCT07148557
Summary
This is an early-stage study to check the safety and how the body processes a new injection called LP-003 in teenagers with allergic diseases. It will involve 6 participants aged 12 to 18 who have conditions like food allergies, asthma, or eczema. The main goal is to see how safe the injection is and to measure its levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Anhui Medical University
Hefei, China
Conditions
Explore the condition pages connected to this study.